@bonkers89 is right. Fully funded with a lean business model.
For the current phase of this company the market cap is just too low.
They have moved from the lab and progressed into a real time working product that is currently undergoing trails with initial results arriving anytime soon.
Pre-FDA is coming at within 3 months.
Think about the market cap if this was a drug company.... you would be talking 6 figures.
Just as much if not more potential here.
@bonker89 as always your investigation into the people behind the company is insightful and spot on.
RAP Price at posting:
2.3¢ Sentiment: None Disclosure: Held
